Exosome therapy is one of the most rapidly evolving areas in both regenerative and aesthetic medicine. Over the past two years, the volume of peer-reviewed research on extracellular vesicles has grown substantially — and so has the clinical evidence supporting their use. At my clinic in JBR Dubai, IV exosome therapy is one of the treatments I offer within a broader longevity and precision aesthetics framework, and I am frequently asked by patients what it actually does, whether it is safe, and who it is right for.

This article answers those questions with reference to the current science.

What Are Exosomes?

Exosomes are nanoscale extracellular vesicles — tiny membrane-enclosed particles between 40 and 160 nanometres in diameter — produced naturally by cells throughout the body. Far from being cellular waste, they function as a sophisticated intercellular communication system, carrying proteins, lipids, and nucleic acids from one cell to another and influencing processes including tissue repair, inflammation regulation, and cell signalling.

When derived from mesenchymal stem cells (MSCs), exosomes inherit many of the regenerative signalling properties of their parent cells — without the risks associated with live cell transplantation. This makes them a compelling therapeutic tool across a range of applications.

What Does IV Exosome Therapy Do?

Delivered intravenously, exosomes enter systemic circulation and can act on multiple organ systems simultaneously. The proposed mechanisms of action include:

• Immune modulation: exosomes have demonstrated strong immunoregulatory properties, helping to reduce chronic low-grade inflammation — one of the central drivers of biological ageing
• Cellular repair signalling: by delivering growth factors and regulatory RNAs to target tissues, exosomes can support regenerative processes at a cellular level
• Skin and tissue rejuvenation: studies in aesthetic medicine have documented improvements in skin quality, elasticity, and tone following exosome-based treatments
• Recovery support: the anti-inflammatory and pro-regenerative properties of exosomes make them relevant for patients recovering from illness, surgery, or prolonged physical stress

What Does the Research Show?

The evidence base for exosome therapy is still maturing, but it is meaningful. A 2024 systematic review and meta-analysis published in the Journal of Extracellular Vesicles (Van Delen et al., 2024) analysed 21 clinical trials assessing the safety and efficacy of human extracellular vesicle-based therapy. The review found that EVs demonstrate low immunogenicity and an ability to cross biological barriers — properties that make them particularly suited to systemic delivery. Importantly, the safety profile across included studies was favourable.

In aesthetic medicine specifically, a systematic review and meta-analysis published in Aesthetic Surgery Journal (2024) evaluated exosome-based therapies across human clinical trials. The review documented evidence supporting exosome efficacy for facial rejuvenation, skin quality improvement, and tissue repair — with an emerging body of data on the anti-ageing mechanisms at play.

A further review in the same journal noted that GMP-compliant exosome preparations are increasingly positioned not as supplementary agents but as primary therapeutic tools in next-generation regenerative protocols.

As with any emerging therapy, I want to be clear with my patients: the evidence is promising and growing, but this is not a field where we have decades of long-term data. I offer IV exosome therapy as part of a scientifically grounded, individually tailored longevity programme — not as a standalone cure-all.

Who Is IV Exosome Therapy For?

In my practice, IV exosome therapy is most appropriate for the following patient profiles:

• Anti-ageing and longevity patients: individuals who are proactively investing in health span, cellular health, and slowing biological ageing
• Post-illness recovery: patients recovering from viral illness, immune dysregulation, or prolonged fatigue who are looking to support the body’s repair mechanisms
• Skin rejuvenation: patients seeking systemic support for skin quality improvement alongside topical or in-clinic aesthetic treatments
• Athletic performance and recovery: athletes or highly active individuals looking to support tissue repair, reduce inflammation, and optimize recovery

IV exosome therapy is not a first-line treatment for acute medical conditions and is not appropriate for every patient. A thorough consultation is always required before treatment is recommended.

What to Expect at My Clinic

At Apogee Clinic in JBR, I take a structured approach to IV exosome therapy. Before recommending treatment, I take a detailed medical history, assess your current health status, and discuss your goals — whether those are primarily longevity-focused, aesthetic, or recovery-related.

I use GMP-certified exosome preparations, which means the product has been manufactured under internationally recognized pharmaceutical standards. This is a non-negotiable requirement for any biological therapy I offer in my practice.

The IV infusion itself typically takes 30 to 60 minutes. Most patients tolerate it well. After initial consultation and deciding on treatment we can administer the IV drip at your home or hotel at your best convenience. Depending on your individual goals, I may recommend a course of treatments spaced over several weeks, often integrated within a broader longevity or aesthetic programme.

A Note on Standards and Regulation

Exosome therapy exists in a rapidly evolving regulatory landscape globally, including in the UAE. I would encourage any patient considering this treatment — at my clinic or elsewhere — to ask the following questions:

I

• Is the exosome product GMP-certified?
• Has the practitioner reviewed your medical history before recommending IV therapy?
• Is the treatment being offered as part of a structured clinical protocol, or simply as an add-on?

At my clinic, the answer to the first two questions is always yes, and exosome therapy is never offered without a proper clinical assessment.

Book a Consultation

If you are interested in exploring IV exosome therapy as part of a longevity or aesthetic programme, I am happy to discuss whether it is appropriate for your individual case.

WhatsApp: +971 52 328 6185

Location: Apogee Clinic, JBR, Dubai

Website: drshivaf.com | @drshivaf